Users Stopping Anti-Obesity Injections Regain Pounds Far More Rapidly Than People Using Diet and Exercise

New research suggests that patients who stop using popular GLP-1 drugs like Wegovy and Mounjaro tend to recover reduced body mass much more quickly than those who stop conventional diet and exercise plans.

Findings released in a prominent health publication shows that while obese individuals can lose substantial amounts of their body weight while using the jabs, the mass comes back at an average rate of 0.8 kg per month upon discontinuation.

"Individuals purchasing such drugs should be aware of the danger of quick rebound weight gain when the therapy concludes," cautioned expert Dr. Susan Jebb.

This pace of regain suggests a reversion to starting mass within about a year and a half.

Weighing Approaches

The research, which reviewed 37 of studies involving thousands of participants, compared the outcomes of these new drugs with conventional dieting.

The team note that individuals who lose weight through diet and exercise typically experience a more gradual creep back—approximately 100 grams monthly—after stopping.

Explaining the Quick Regain

Nutrition scientists suggest the mechanism of the drugs is key to understanding the heightened regain.

The injections imitate a body's own chemical called glucagon-like peptide-1, which moderates hunger.

"Sustained high doses of the hormone levels far above than normal may cause the system to produce less of its own natural GLP-1, and could diminish responsiveness to its actions," said Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this medication means hunger is unsuppressed, making overeating far more likely."

A Chronic Condition?

Medical guidelines advise the jabs for individuals with obesity-related health risks, alongside prescribed lifestyle changes.

A number of clinicians say that, due to the significant potential of weight regain, the treatment should be considered long-term.

This perspective is reinforced by pharmaceutical companies, who note that the results "highlight the chronic character of obesity," comparing it to managing diseases like diabetes.

Patient Experiences

Users who have come off the jabs report a powerful return of cravings.

"It was like a trigger flipping and you're instantly starving," described a patient.

The struggle is exacerbated if users have not adopted permanent lifestyle or habit changes during treatment.

Widespread Use

Recent estimates suggest that millions of adults in the UK have used weight-loss jabs in the last 12 months, with desire being substantial.

• Use is higher among females compared to men.
• The middle-aged demographic shows the greatest level of interest.
• A large proportion access the medications through private prescriptions rather than the NHS.

Finally, clinicians emphasize that while these medications are effective agents for shedding pounds, they are not a standalone solution and long-term success likely depends on ongoing lifestyle support.